Stock DRW3 DRÄGERWERK AG & CO. KGAA
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Drägerwerk AG & Co. KGaA

Equities

DRW3

DE0005550636

Real-time Estimate Tradegate
Other stock markets
 11:42:07 2024-04-25 am EDT 		5-day change 1st Jan Change
49.18 EUR -2.24% Intraday chart for Drägerwerk AG & Co. KGaA +1.33% -4.05%
Apr. 16 DRÄGERWERK AG & CO KGAA : Silver lining beyond the soft Q124 headline figures Alphavalue
Apr. 16 DRAEGERWERK : Hauck & Aufhauser remains its Buy rating ZD

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.
  • The company has a good ESG score relative to its sector, according to Refinitiv.

Strengths

  • With a P/E ratio at 10.89 for the current year and 8.89 for next year, earnings multiples are highly attractive compared with competitors.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.31 for the 2024 fiscal year.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
DRÄGERWERK AG & CO. KGAA Stock Drägerwerk AG & Co. KGaA
-4.05% 937M
B+
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.83% 220B
B
DANAHER CORPORATION Stock Danaher Corporation
+6.57% 185B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+9.71% 133B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.79% 107B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.30% 62.91B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.54% 53.34B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.89% 47.71B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-2.65% 40.29B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+9.71% 39.57B -
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DRW3 Stock
  4. Ratings Drägerwerk AG & Co. KGaA